Company recognized for treatment recently approved in the U.S. for pediatric acute kidney injury (AKI) due to sepsis. NEW YORK, March 18, 2025 /PRNewswire/ — SeaStar Medical (Nasdaq: ICU) has been selected to receive the 2025 Corporate Innovator Award from the National Kidney Foundation…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.